- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-43-0052980

Jyotishri Pharmaceuticals Private Limited
About Jyotishri Pharmaceuticals Private Limited
Data last updated:
Jyotishri Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U36990UP2017PTC088884. Its GSTIN is 09AADCJ8878M1ZL (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Shanker Gupta and Anand Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 378 Lakhanpur Housing Society, Kanpur, Uttar Pradesh, India – 208024.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.86 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹5.43 Lakh (net margin 2.9%) and EBITDA of ₹9.37 Lakh (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹43.4 Lakh on record.
Jyotishri Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0052980). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Jyotishri Pharmaceuticals
Contact details
Jyotishri Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 378 Lakhanpur Housing Society, Kanpur, Uttar Pradesh, India – 208024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jyotishri Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jyotishri Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Jyotishri Pharmaceuticals Private Limited, buy the company report.
Financials of Jyotishri Pharmaceuticals Private Limited
FY 2025 filings availableJyotishri Pharmaceuticals Private Limited reported revenue of ₹1.86 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 7% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jyotishri Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jyotishri Pharmaceuticals Private Limited
Jyotishri Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Shanker Gupta | Director | 03 Jan 2017 | 9 Years 10 Months | Current |
| Anand Kumar | Director | 03 Jan 2017 | 9 Years 10 Months | Current |
Auditor
Jyotishri Pharmaceuticals Private Limited is audited by PRADEEP SHIV & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRADEEP SHIV & ASSOCIATES | FY 2018 | 010274C |
Shareholding
The shareholding of Jyotishri Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Jyotishri Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jun 2020 | 100379488 | Canara Bank | ₹3.4 Lakh | Open | |
| 13 Sep 2017 | 100134621 | Canara Bank | ₹40 Lakh | Open |
To see the full charge records of Jyotishri Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Jyotishri Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jyotishri Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jyotishri Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCJ8878M1ZL | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jyotishri Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jyotishri Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anand Kumar was appointed as Director on 03 Jan 2017.
Frequently asked questions
Jyotishri Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 January 2017 (9+ years old) and is registered under CIN U36990UP2017PTC088884.
Jyotishri Pharmaceuticals has 2 current directors:
- Ravi Shanker Gupta - Director
- Anand Kumar - Director
The latest financial statements of Jyotishri Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Jyotishri Pharmaceuticals is 09AADCJ8878M1ZL, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Jyotishri Pharmaceuticals is U36990UP2017PTC088884. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jyotishri Pharmaceuticals was incorporated on 03 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Anand Kumar was appointed as Director on 03 Jan 2017. Ravi Shanker Gupta was appointed as Director on 03 Jan 2017.
Yes, Jyotishri Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0052980).
The registered office of Jyotishri Pharmaceuticals is at Plot No. 378 Lakhanpur Housing Society, Kanpur, Uttar Pradesh, India – 208024.
Jyotishri Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

